1. P05.81 Neurocognitive assessment in cancer patients without central nervous system disease treated with bevacizumab at week 34: an observational transversal multi-centric pilot study. (19th September 2018) Authors: Panciroli, C; Lucente, G; Cecilia, O; Quiroga, V; Carcereny, E; Pardo, J; Romeo, M; Velarde, J; Villa, S; Balaña, C Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii322 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗